TP53 and nasopharyngeal carcinoma: Aside from targeting mRNA, EBV-miRNA5-3p also facilitates the degradation of the p53 protein, a process that leads to the inhibition of cell cycle arrest and apoptosis and enhances the progression of NPC [113].